Just jumped on the GDY bandwagon, beleive it or not looks like it is actually going to run. I like the Gap up from over sold and just a light pull back.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
